Description
This product is a recombinant antibody that recognizes SLAMF7. The monoclonal antibody Ilofuzumab reacts with the epitope of SLAMF7. A combination of Ilofuzumab and wherein -PD1 antibody showed a synergistic anti-tumor activity.
Target
SLAMF7
Target Alias Names
SLAM Family Member 7, Membrane Protein FOAP-12, CD2 Subset 1, Protein 19A, CRACC, CS1, Novel LY9 (Lymphocyte Antigen 9) Like Protein, CD2-Like Receptor Activating Cytotoxic Cells
Isotype/Mimetic
Humanized IgG2a
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression